Insights
Welcome to the PortiVix resource hub
A quick look at how our editorial team publishes practical guides on pharma portfolio and project governance.
PortiVix Editorial · 5 July 2026
This space is where the PortiVix editorial and marketing team shares practical thinking on how pharma organisations move from spreadsheet-driven reporting to a governed operating model.
What you will find here
Short, decision-focused explainers written for the people who actually run portfolio reviews, phase gates, and audits:
- How risk scoring like PTRS feeds go/no-go decisions
- Why eNPV changes how you prioritise a pipeline
- What audit-ready governance looks like day to day
Our goal is simple: make the decision defensible, and the evidence ready before anyone asks “what changed?”
Written by practitioners
Every piece is grounded in real pharma operating pressure - API and formulation timelines, regulatory milestones, material readiness, and the reviews that decide where capital goes next.
This article is general information. It is not legal, regulatory, financial or investment advice. Figures and examples are illustrative.